Suppr超能文献

[重排影响甲状腺乳头状癌的多灶性形成]

[/ rearrangement affects multifocal formation of papillary thyroid carcinoma].

作者信息

Zhang X, Su X, Chen W C, Li Y, Yang Z Y, Deng W Z, Deng T C, Yang A K

机构信息

Department of Head and Neck Surgery, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China.

出版信息

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Jun 7;52(6):435-439. doi: 10.3760/cma.j.issn.1673-0860.2017.06.008.

Abstract

/ gene rearrangement can lead to aberrant activation of tyrosine kinase receptors, which is a common mutation in papillary thyroid carcinoma (PTC). This study focuses on the association of / rearrangements with PTC clinical factors. From January 2011 to December 2013, a total of 114 patients with PTC were enrolled in this study. Clinicopathological parameters, lifestyle, and thyroid hormone levels were collected. / rearrangements were detected by TaqMan PCR and verified by Sanger sequencing.Data were analyzed with SPSS software, including chi-square test, ' exact test, - test, '-test, and Logistic regression. / rearrangements were not found in all paracancerous normal thyroid tissues, and were detected in 23.68% (27/114) of PTC. Further analysis revealed no correlation between / rearrangement and thyroid function, clinicopathologic parameters, and lifestyle in the total PTC group or in the subgroup of patients with concomitant diseases (including Hashimoto's thyroiditis and nodular goiter). But in the subgroup of PTC without concomitant disease, / rearrangement was associated with tumor multifocal (=0.018), and /-positive PTC patients had an increased risk of tumor multifocal (=5.57, 95% 1.39-22.33). It was also found that / rearrangement was associated with an abnormal increase in TSH level of one month after surgery (= 0.037). Nodular goiter and Hashimoto 's thyroiditis may be a confounding factor in PTC. / rearrangement may play an important role in the occurrence of thyroid carcinoma multifocal after exclusion of this confounding factor.

摘要

/基因重排可导致酪氨酸激酶受体异常激活,这是甲状腺乳头状癌(PTC)中常见的突变。本研究聚焦于/重排与PTC临床因素的关联。2011年1月至2013年12月,本研究共纳入114例PTC患者。收集了临床病理参数、生活方式和甲状腺激素水平。通过TaqMan PCR检测/重排,并通过桑格测序进行验证。使用SPSS软件进行数据分析,包括卡方检验、确切概率检验、t检验、t'检验和逻辑回归。在所有癌旁正常甲状腺组织中均未发现/重排,在23.68%(27/114)的PTC中检测到。进一步分析显示,在整个PTC组或伴有疾病(包括桥本甲状腺炎和结节性甲状腺肿)的患者亚组中,/重排与甲状腺功能、临床病理参数和生活方式之间无相关性。但在无伴发疾病的PTC亚组中,/重排与肿瘤多灶性相关(P = 0.018),/阳性的PTC患者发生肿瘤多灶性的风险增加(P = 5.57,95%CI 1.39 - 22.33)。还发现/重排与术后1个月TSH水平异常升高相关(P = 0.037)。结节性甲状腺肿和桥本甲状腺炎可能是PTC中的一个混杂因素。排除该混杂因素后,/重排在甲状腺癌多灶性的发生中可能起重要作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验